Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Angiodynamics (ANGO) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Angiodynamics (ANGO) over the last 15 years, with Q2 2025 value amounting to $70.7 million.

  • Angiodynamics' Accumulated Depreciation & Amortization fell 251.29% to $70.7 million in Q2 2025 from the same period last year, while for May 2025 it was $70.7 million, marking a year-over-year decrease of 251.29%. This contributed to the annual value of $70.7 million for FY2025, which is 251.29% down from last year.
  • Per Angiodynamics' latest filing, its Accumulated Depreciation & Amortization stood at $70.7 million for Q2 2025, which was down 251.29% from $72.5 million recorded in Q2 2024.
  • Angiodynamics' 5-year Accumulated Depreciation & Amortization high stood at $72.5 million for Q2 2024, and its period low was $45.2 million during Q2 2021.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $58.5 million (2023), whereas its average is $59.5 million.
  • In the last 5 years, Angiodynamics' Accumulated Depreciation & Amortization soared by 2394.03% in 2024 and then plummeted by 251.29% in 2025.
  • Quarter analysis of 5 years shows Angiodynamics' Accumulated Depreciation & Amortization stood at $45.2 million in 2021, then rose by 11.99% to $50.6 million in 2022, then grew by 15.73% to $58.5 million in 2023, then rose by 23.94% to $72.5 million in 2024, then dropped by 2.51% to $70.7 million in 2025.
  • Its Accumulated Depreciation & Amortization was $70.7 million in Q2 2025, compared to $72.5 million in Q2 2024 and $58.5 million in Q2 2023.